Alpha 2.0
Login Register
» Articles » PMID: 30991920

Nose-to-brain Delivery of Biologics

Overview
Journal Ther Deliv
Date 2019 Apr 18
PMID 30991920
Citations 8
Authors
Bettina Schwarz
Olivia M Merkel
Affiliations
Soon will be listed here.
Abstract

Graphical abstract.

Citing Articles

Ketamine and Esketamine in Clinical Trials: FDA-Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations.

Vekhova K, Namiot E, Jonsson J, Schioth H Clin Pharmacol Ther. 2024; 117(2):374-386.

PMID: 39428602 PMC: 11739757. DOI: 10.1002/cpt.3478.

Non-Invasive Device-Mediated Drug Delivery to the Brain across the Blood-Brain Barrier.

Tashima T, Tournier N Pharmaceutics. 2024; 16(3).

PMID: 38543255 PMC: 10974733. DOI: 10.3390/pharmaceutics16030361.

Lipid-based nanoparticles via nose-to-brain delivery: a mini review.

Xinchen Y, Jing T, Jiaoqiong G Front Cell Dev Biol. 2023; 11:1214450.

PMID: 37675144 PMC: 10477605. DOI: 10.3389/fcell.2023.1214450.

Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients.

Jin Z, Han Y, Zhang D, Li Z, Jing Y, Hu B Pharmaceutics. 2022; 14(10).

PMID: 36297505 PMC: 9611373. DOI: 10.3390/pharmaceutics14102070.

Improving Drug Delivery for Alzheimer's Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels.

Cunha S, Forbes B, Sousa Lobo J, Silva A Int J Nanomedicine. 2021; 16:4373-4390.

PMID: 34234432 PMC: 8256381. DOI: 10.2147/IJN.S305851.